572 related articles for article (PubMed ID: 18524643)
1. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomised controlled trial with a 2-year follow-up.
Ouvry P; Allaert FA; Desnos P; Hamel-Desnos C
Eur J Vasc Endovasc Surg; 2008 Sep; 36(3):366-70. PubMed ID: 18524643
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency.
Yamaki T; Nozaki M; Iwasaka S
Dermatol Surg; 2004 May; 30(5):718-22; discussion 722. PubMed ID: 15099313
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-guided sclerotherapy of the great saphenous vein with 1% vs. 3% polidocanol foam: a multicentre double-blind randomised trial with 3-year follow-up.
Blaise S; Bosson JL; Diamand JM
Eur J Vasc Endovasc Surg; 2010 Jun; 39(6):779-86. PubMed ID: 20206556
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
Rabe E; Otto J; Schliephake D; Pannier F
Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. "The 3/1 Study".
Hamel-Desnos C; Ouvry P; Benigni JP; Boitelle G; Schadeck M; Desnos P; Allaert FA
Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):723-9; discussion 730. PubMed ID: 17884623
[TBL] [Abstract][Full Text] [Related]
6. Catheter-assisted vein sclerotherapy: a new approach for sclerotherapy of the greater saphenous vein with a double-lumen balloon catheter.
Brodersen JP; Geismar U
Dermatol Surg; 2007 Apr; 33(4):469-75. PubMed ID: 17430382
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.
Hamel-Desnos C; Desnos P; Wollmann JC; Ouvry P; Mako S; Allaert FA
Dermatol Surg; 2003 Dec; 29(12):1170-5; discussion 1175. PubMed ID: 14725657
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical trial of ultrasound-guided foam sclerotherapy versus surgery for the incompetent great saphenous vein.
Shadid N; Ceulen R; Nelemans P; Dirksen C; Veraart J; Schurink GW; van Neer P; vd Kley J; de Haan E; Sommer A
Br J Surg; 2012 Aug; 99(8):1062-70. PubMed ID: 22627969
[TBL] [Abstract][Full Text] [Related]
9. Prospective randomised comparative study of visual foam sclerotherapy alone or in combination with ultrasound-guided foam sclerotherapy for treatment of superficial venous insufficiency: preliminary report.
Yamaki T; Hamahata A; Soejima K; Kono T; Nozaki M; Sakurai H
Eur J Vasc Endovasc Surg; 2012 Mar; 43(3):343-7. PubMed ID: 22230599
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-guided foam sclerotherapy for the treatment of varicose veins.
Darke SG; Baker SJ
Br J Surg; 2006 Aug; 93(8):969-74. PubMed ID: 16739097
[TBL] [Abstract][Full Text] [Related]
11. Immediate pathologic effects on the vein wall of foam sclerotherapy.
Orsini C; Brotto M
Dermatol Surg; 2007 Oct; 33(10):1250-4. PubMed ID: 17903159
[TBL] [Abstract][Full Text] [Related]
12. Endovenous laser and echo-guided foam ablation in great saphenous vein reflux: one-year follow-up results.
Gonzalez-Zeh R; Armisen R; Barahona S
J Vasc Surg; 2008 Oct; 48(4):940-6. PubMed ID: 18639418
[TBL] [Abstract][Full Text] [Related]
13. Results of Ultrasound-Guided Foam Sclerotherapy of the Great Saphenous Vein With New Parameters of the Technique.
Baeshko A; Shestak N; Korytko S
Vasc Endovascular Surg; 2016 Nov; 50(8):528-533. PubMed ID: 27837181
[TBL] [Abstract][Full Text] [Related]
14. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.
Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):343-8. PubMed ID: 18922712
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: results of a randomized controlled trial with 1-year follow-up.
Ceulen RP; Bullens-Goessens YI; Pi-VAN DE Venne SJ; Nelemans PJ; Veraart JC; Sommer A
Dermatol Surg; 2007 Mar; 33(3):276-81. PubMed ID: 17338683
[TBL] [Abstract][Full Text] [Related]
16. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
Uncu H
Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
[TBL] [Abstract][Full Text] [Related]
17. Catheter-directed foam sclerotherapy of great saphenous veins in combination with pre-treatment reduction of the diameter employing the principals of perivenous tumescent local anesthesia.
Devereux N; Recke AL; Westermann L; Recke A; Kahle B
Eur J Vasc Endovasc Surg; 2014 Feb; 47(2):187-95. PubMed ID: 24268395
[TBL] [Abstract][Full Text] [Related]
18. Changes in calf muscle deoxygenation after foam sclerotherapy in patients with superficial venous insufficiency.
Yamaki T; Konoeda H; Fujisawa D; Ogino K; Osada A; Hamahata A; Nozaki M; Sakurai H
J Vasc Surg; 2012 Dec; 56(6):1649-55. PubMed ID: 22608181
[TBL] [Abstract][Full Text] [Related]
19. Comparison of efficacy and safety between foam sclerotherapy and conventional sclerotherapy: a controlled clinical trial.
Ukritmanoroat T
J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S35-40. PubMed ID: 21717876
[TBL] [Abstract][Full Text] [Related]
20. Catheter-directed foam sclerotherapy of axial saphenous reflux: early results.
Kölbel T; Hinchliffe RJ; Lindblad B
Phlebology; 2007; 22(5):219-22. PubMed ID: 18269073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
